ARIS vs. ZVRA

Last updated Jun 13, 2026

ARIS (Aris Water Solutions, Inc.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. ARIS operates in Utilities - Regulated Water (Utilities), while ZVRA operates in Biotechnology (Healthcare). Over the past 3 years, ARIS returned 88.30%/yr vs 29.54%/yr for ZVRA. At a 0.11 correlation, their price movements are largely independent.

Performance

ARIS vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aris Water Solutions, Inc. (ARIS) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARIS achieves a -2.09% return, which is significantly lower than ZVRA's 41.18% return.

ARIS

• 1D: 5.23%
• 1M: -19.38%
• YTD: -2.09%
• 6M: 1.15%
• 1Y: 135.76%
• 3Y*: 88.30%
• 5Y*: —
• 10Y*: —

ZVRA

• 1D: -2.47%
• 1M: 13.76%
• YTD: 41.18%
• 6M: 51.86%
• 1Y: 35.01%
• 3Y*: 29.54%
• 5Y*: -2.85%
• 10Y*: -16.40%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARIS vs. ZVRA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ARIS Aris Water Solutions, Inc.	-2.09%	363.71%	6.54%	31.93%	-39.60%	1.33%
ZVRA Zevra Therapeutics Inc.	41.18%	7.43%	27.33%	42.70%	-47.30%	-10.57%

Correlation

The correlation between ARIS and ZVRA is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (All Time) Calculated using the full available price history since Oct 22, 2021	0.11

Fundamentals

Market Cap ARIS : $3.32B ZVRA : $761.92M
EPS ARIS : $0.87 ZVRA : $2.16
PE Ratio ARIS : 18.19 ZVRA : 5.85
PS Ratio ARIS : 2.76 ZVRA : 5.94
PB Ratio ARIS : 2.11 ZVRA : 3.70
Total Revenue (TTM) ARIS : $1.14B ZVRA : $122.29M
Gross Profit (TTM) ARIS : $612.94M ZVRA : $104.94M
EBITDA (TTM) ARIS : $432.53M ZVRA : $149.15M

Return for Risk

ARIS vs. ZVRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARIS

ARIS Risk / Return Rank: 92
ARIS Sharpe Ratio Rank: 95
ARIS Sortino Ratio Rank: 88
ARIS Omega Ratio Rank: 89
ARIS Calmar Ratio Rank: 92
ARIS Martin Ratio Rank: 95

ZVRA

ZVRA Risk / Return Rank: 60
ZVRA Sharpe Ratio Rank: 61
ZVRA Sortino Ratio Rank: 62
ZVRA Omega Ratio Rank: 61
ZVRA Calmar Ratio Rank: 60
ZVRA Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARIS vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aris Water Solutions, Inc. (ARIS) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ARIS	ZVRA	Difference
Sharpe ratio: Return per unit of total volatility	2.87	0.56	+2.31
Sortino ratio: Return per unit of downside risk	2.81	1.27	+1.54
Omega ratio: Gain probability vs. loss probability	1.40	1.16	+0.24
Calmar ratio: Return relative to maximum drawdown	4.87	0.81	+4.06
Martin ratio: Return relative to average drawdown	16.85	1.41	+15.44

ARIS vs. ZVRA - Sharpe Ratio Comparison

The current ARIS Sharpe Ratio is 2.87, which is higher than the ZVRA Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of ARIS and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ARIS vs. ZVRA - Drawdown Comparison

The maximum ARIS drawdown since its inception was -57.98%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for ARIS and ZVRA.

Drawdown Indicators

	ARIS	ZVRA	Difference
Max Drawdown Largest peak-to-trough decline	-57.98%	-99.27%	+41.29%
Max Drawdown (1Y) Largest decline over 1 year	-34.32%	-43.47%	+9.15%
Max Drawdown (3Y) Largest decline over 3 years	-34.46%	-43.47%	+9.01%
Max Drawdown (5Y) Largest decline over 5 years	—	-74.01%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-97.85%	—
Current Drawdown Current decline from peak	-26.61%	-96.65%	+70.04%
Average Drawdown Average peak-to-trough decline	-22.67%	-86.41%	+63.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.35%	24.87%	-15.52%

Volatility

ARIS vs. ZVRA - Volatility Comparison

The current volatility for Aris Water Solutions, Inc. (ARIS) is 21.05%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 24.56%. This indicates that ARIS experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARIS	ZVRA	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.05%	24.56%	-3.51%
Volatility (6M) Calculated over the trailing 6-month period	46.30%	40.23%	+6.07%
Volatility (1Y) Calculated over the trailing 1-year period	58.35%	62.90%	-4.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.11%	60.49%	-7.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	53.11%	81.46%	-28.35%

Dividends

ARIS vs. ZVRA - Dividend Comparison

Neither ARIS nor ZVRA has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
ARIS Aris Water Solutions, Inc.	0.00%	0.00%	0.00%	0.00%	3.84%	0.85%
ZVRA Zevra Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both ARIS and ZVRA in my portfolio?

ARIS and ZVRA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARIS or ZVRA?

ZVRA has higher volatility (24.56%) compared to ARIS (21.05%). In terms of maximum drawdown, ARIS dropped -57.98% vs ZVRA's -99.27%.

Which has better risk-adjusted returns?

ARIS currently has the higher Sharpe Ratio (2.87 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.